These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9106142

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Water as a contrast medium: a re-evaluation using the multidetector-row computed tomography.
    Makarawo TP, Negussie E, Malde S, Tilak J, Gayagoy J, Watson J, Francis F, Lincoln D, Jacobs MJ.
    Am Surg; 2013 Jul; 79(7):728-33. PubMed ID: 23816008
    [Abstract] [Full Text] [Related]

  • 23. Optimization of a negative oral contrast agent for magnetic resonance imaging.
    Davis MA, Mei H, Ritsema GH.
    Invest Radiol; 1994 Jun; 29 Suppl 2():S120-2. PubMed ID: 7928205
    [No Abstract] [Full Text] [Related]

  • 24. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C.
    Acta Radiol Suppl; 1998 Jun; 415():1-31. PubMed ID: 9571956
    [Abstract] [Full Text] [Related]

  • 25. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
    Patten RM, Lo SK, Phillips JJ, Bowman SC, Glazer GM, Wall SD, Bova JG, Harris RD, Wheat RL, Johnson CD.
    Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
    [Abstract] [Full Text] [Related]

  • 26. Use of nutritional support formula as a gastrointestinal contrast agent for MRI.
    Mirowitz SA, Susman N.
    J Comput Assist Tomogr; 1992 Oct; 16(6):908-15. PubMed ID: 1430440
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Magnetic resonance tomography: value and limits in gastroenterologic diagnosis].
    Laniado M, Duda S, Claussen CD.
    Bildgebung; 1992 Jun; 59(2):61-7. PubMed ID: 1511212
    [Abstract] [Full Text] [Related]

  • 30. A potentially artifact-free oral contrast agent for gastrointestinal MRI.
    Liebig T, Stoupis C, Ros PR, Ballinger JR, Briggs RW.
    Magn Reson Med; 1993 Nov; 30(5):646-9. PubMed ID: 8259066
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Contrast-enhanced magnetic resonance imaging of the abdomen.
    Brown ED, Semelka RC.
    Magn Reson Q; 1994 Jun; 10(2):97-124. PubMed ID: 7986704
    [Abstract] [Full Text] [Related]

  • 34. [Oral contrast medium for magnetic resonance tomography of the abdomen. II. Phase I clinical testing of gadolinium-DTPA].
    Kornmesser W, Laniado M, Hamm B, Clauss W, Weinmann HJ, Schulz E, Wolf KJ, Felix R.
    Rofo; 1987 Nov; 147(5):550-6. PubMed ID: 2825293
    [Abstract] [Full Text] [Related]

  • 35. Impact of low-energy CT imaging on selection of positive oral contrast media concentration.
    Patino M, Murcia DJ, Iamurri AP, Kambadakone AR, Hahn PF, Sahani DV.
    Abdom Radiol (NY); 2017 May; 42(5):1298-1309. PubMed ID: 27933477
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S, Laniado M, Gogoll M, Kornmesser W, Clauss W, Felix R.
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.